spacer
home > white papers > The Rare Disease Patients Experience
WHITE PAPERS

The Rare Disease Patients Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
Download the White Paper
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Bormioli Pharma Reveals at CPHI Frankfurt New Prototypes Focusing on Effective, Patient-Centered Innovation

Parma, 19 October 2022 - Bormioli Pharma, an international leader in the production of pharmaceutical packaging and medical devices, will attend at CPHI in Frankfurt (booth 30B20) showcasing a service-driven, innovative and sustainable product offer and reaffirming its positioning as “one-stop shop” partner for the pharma industry.
More info >>


White Papers


©2000-2011 Samedan Ltd.
Add to favourites

Print this page
Send to a friend
Privacy statement